Icotinib Hydrochloride Cream in Patients With Mild to Moderate Psoriasis

NCT02801435 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

41

Enrollment

INDUSTRY

Sponsor class

Conditions

Psoriasis

Interventions

DRUG: 0.5% Icotinib hydrochloride cream
DRUG: 1.0% Icotinib hydrochloride cream
DRUG: 2.0% Icotinib hydrochloride cream
DRUG: 4.0% Icotinib hydrochloride cream
DRUG: Placebo

Sponsor

Betta Pharmaceuticals Co., Ltd.

Collaborators

[object Object]